In Marijuana Venture’s roundtable on hemp-derived product regulation, CannaPlanners contributed to a growing consensus: the future of cannabinoids like Delta-8 and THC-P requires federal clarity. The article emphasizes the need for safety, labeling, and compliance frameworks to protect both businesses and consumers.

Read the Full Article in Marijuana Venture